Posts from ‘May, 2010’

AnchorPort® SIL Kit provides visualization during abdominal entry for enhanced safety and self-adjusts to patient’s abdominal wall thickness to optimize instrument maneuverability during single skin incision laparoscopic surgery ORANGE, Conn., May 2…
Devices, Surgery, FDA
SurgiQuest, AnchorPor, Single Incision Laparoscopy

Morepen Laboratories Limited to market AccuVein AV300, first portable, non-contact vein finder COLD SPRING HARBOR, N.Y., May 18 (HSMN NewsFeed) — AccuVein LLC today announced it had signed an exclusive distribution agreement with the Medipath Divisio…
Devices, Distribution
AccuVein, venipuncture

ALACHUA, Fla.–(HSMN NewsFeed)–AxoGen, Inc. announced today the promotion of Karen Zaderej to the position of Chief Executive Officer. Ms. Zaderej was formerly the Chief Operating Officer. Former AxoGen CEO, Jamie Grooms has retained the role of Chairman …
Devices, Personnel
AxoGen, Avance Nerve Graft, AxoGuard Nerve Connector, AxoGuard Nerve Protector

One of Two Cancer Centers in the Tri-State Area Currently Implanting Same Day Radiation Dose Adjustment for Prostate Cancer Treatment HACKENSACK, N.J., May 17 (HSMN NewsFeed) — John Theurer Cancer Center at Hackensack University Medical Center announ…
Devices, Oncology
Sicel Technologies, Dose Verification System, radiotherapy, prostate cancer

JERUSALEM–(HSMN NewsFeed)–Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA ) today announced results from the Phase II ALSTAR trial. The trial was designed to assess efficacy, safety and tolerability of Talampanel (a selective AMPA antagonist) in reduci…
Biopharmaceuticals, Neurology
Teva Pharmaceutical, Talampanel, Amyotrophic Lateral Sclerosis

SAN DIEGO, May 17 (HSMN NewsFeed) — Halozyme Therapeutics, Inc. (Nasdaq:HALO ) today announced that Halozyme and Baxter have confirmed the presence of tiny flake-like glass particles in a limited number of vials of HYLENEX® (hyaluronidase human inj…
Biopharmaceuticals, Product Recall
Halozyme Therapeutics, Baxter, HYLENEX, hyaluronidase

Radioactive Seeds Used to Identify Non-Palpable Breast Lesions DUBLIN, Ohio–(HSMN NewsFeed)–Neoprobe Corporation (OTCBB: NEOP ), a diversified developer of innovative biomedical surgical oncology products, today announced that its gamma radiation dete…
Devices, Surgery, Oncology
Neoprobe, neo2000, radioactive seed localization, gamma camera

Stapler Innovation Addresses Current Challenges in Treating Rectal Prolapse and Hemorrhoid Disease NORTH HAVEN, Conn.–(HSMN NewsFeed)–Covidien (NYSE: COV ), a top global provider of healthcare products, today announced that it is entering the hemo…
Devices
Covidien, hemorrhoidopexy, EEA Hemorrhoid, Prolapse Stapler

ANN ARBOR, Mich., May 17, 2010 –(HSMN NewsFeed) — Aastrom Biosciences, Inc. (Nasdaq:ASTM ), the big developer of autologous cellular therapies for the treatment of severe cardiovascular diseases, today announced that the first patient has been treate…
Regenerative Medicine, Interventional Cardiology
Aastrom Biosciences, dilated cardiomyopathy, tissue repair cells

(Ketorolac Tromethamine) First Non-narcotic Intranasal Analgesic for Moderate to Moderately Severe Pain MENLO PARK, Calif., May 17 (HSMN NewsFeed) — ROXRO PHARMA, Inc. (www.roxropharma.com) announced today that the U.S. Food and Drug Administratio…
Biopharmaceuticals, Drug Delivery, FDA
ROXRO PHARMA, SPRIX Nasal Spray, ketorolac